Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
12/2008
12/02/2008US7459475 less side effects; higher potency; chronic and neuropathic pain, epilepsy, manic depression, bipolar disorder, diabetic neuropathy; 3-[3-(2-Trifluoromethoxyphenyl)-phenyl]-1,2,4-triazole
12/02/2008US7459474 1,2,4 triazole nonsteroidal derivatives; diseases associated with nuclear factor kappa beta induced transcription
11/2008
11/27/2008WO2008144275A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293602 Glycerol derivatives and methods of making same
11/27/2008CA2684764A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008EP1994014A1 Improved process for high purity anastrozole
11/20/2008WO2008138912A1 Use of iron chelator for the treatment of myocardial infarction
11/20/2008US20080287681 Substituted Benzimidazoles and their Use for Inducing Apoptosis
11/20/2008US20080287503 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080286607 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption
11/20/2008CA2685043A1 Use of iron chelator for the treatment of myocardial infarction
11/19/2008EP1991514A1 Novel anthracene derivative and organic electronic device using the same
11/19/2008EP1751131B1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
11/19/2008CN101307028A Benz triazolinone compounds and uses thereof
11/19/2008CN101307027A New method for preparing anastrozole
11/19/2008CN101307026A Blue luminescence organic compound and method for synthesizing same
11/19/2008CN101307018A Diethylene triaminepentaacetic acid carboxyl active ester or analogues, method for synthesizing same and use
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008CA2519252C Biaryl substituted triazoles as sodium channel blockers
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2331187C Water soluble azoles as broad-spectrum antifungals
11/18/2008CA2305802C Amide derivatives or salts thereof
11/13/2008WO2008135767A1 New triazole compounds useful in the treatment of inflammation
11/13/2008WO2008097640A8 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008US20080280869 Therapy for diseases resulting from mutation of messenger Rna; suppression prenature translation termination; autoimmune diseases; blood disorders; collagen disease; diabetes; neurodegenerative diseases; cardiovascular disorders; central nervous system disorders; antiinflammatory agents
11/12/2008EP1990338A2 Biphenylcyclopropylamides as p-38 Kinase inhibitors
11/12/2008CN101305041A Photolatent systems
11/12/2008CN101304981A P2x7 receptor antagonists and methods of use
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449266 Perfluoropolyether benzotriazole compounds
11/06/2008WO2008134674A1 Uv-absorbers for ophthalmic lens materials
11/06/2008WO2008134058A1 Dechalcogenative methods for the preparation of allylic sulfides
11/06/2008WO2008090565B1 Novel thermodynamically stable polymorphic form-l of letrozole
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008CA2685595A1 Dechalcogenative methods for the preparation of allylic sulfides
11/06/2008CA2683002A1 Uv-absorbers for ophthalmic lens materials
11/05/2008EP1988083A1 Triazole derivative
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300236A Triazole compounds as lipoxygenase inhibitors
11/05/2008CN100430390C Water-soluble triazole fungicide
11/05/2008CN100430373C Biological active compound of methoxy acrylic ester containing bis trifluoromethyl phenyl and preparing process thereof
11/04/2008US7446119 particularly phytophagous mites; 1-methylethyl 2-(4-methoxy-[1,1'-biphenyl]-3-yl)-4-methyl-1,2,4-triazolidine-1-carboxylate
10/2008
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080269218 using a triazole compound; anticancer agent
10/30/2008US20080266519 Uv-absorbers for ophthalmic lens materials
10/29/2008EP1687284B1 p-38 KINASE INHIBITORS
10/29/2008EP1606269B1 Biaryl substituted triazoles as sodium channel blockers
10/29/2008CN100429203C Dyeing compsn. for kerationous fibres comprising particular dicationic diazo dye
10/28/2008US7442760 electroluminescent end capped polyarylenes, for use in electronics such as organic light emitting diodes, having high luminous efficiency and durability
10/28/2008CA2331141C Water soluble azoles as broad-spectrum antifungals
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008125342A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008US20080262060 novel crystalline forms of deferasirox, methods for their production, and methods for conversion of the novel forms to the known crystalline form I.
10/23/2008US20080261987 Substituted piperazines
10/23/2008CA2683461A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981860A2 Conversion of aromatic diazonium salt to aryl hydrazine
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008CN101291918A Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101289428A Biaryl substituted triazoles as sodium channel blockers
10/16/2008WO2008124703A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2007002720A8 An impurity of anastrozole intermediate, and uses thereof
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255216 Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition
10/16/2008CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/15/2008EP1979333A1 Process for preparing iodinated azoles
10/15/2008EP1979332A1 Chemical compounds
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/14/2008US7435752 N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitors
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008119662A1 Non-nucleoside reverse transcriptase inhibitors
10/09/2008WO2008033793A3 Synthesis of methyl nonactate derivatives
10/09/2008US20080249151 Non-nucleoside reverse transcriptase inhibitors
10/09/2008US20080249149 Serotonin receptor antagonists
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249131 treatment of HIV; N-(2-Bromo-4-methylphenyl)-2-(5-methyl-4-phenyl-4H-[1,2,4]triazole-3-ylsulfanyl)-acetamide
10/09/2008US20080249106 3-(1-((R)-7-((4-fluoropiperidin-1-yl)methyl)-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)-2-(4-methylphenylsulfonamido)propanoic acid; chronic pain analgesics; side effect reduction
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008CA2682637A1 Non-nucleoside reverse transcriptase inhibitors
10/08/2008EP1976832A2 Azole compounds used as tuberculostatic and leishmanicide agents
10/08/2008CN101279953A Triazole derivatives used in therapy and medicine salt thereof
10/07/2008US7432291 Anticancer, antitumor agents; compounds are 1-(2-(phenethenyl)oxazol-4-ylmethoxy)-4-(1,2,3-triazolylethoxymethyl)-benzenes or corresponding derivatives where oxazole is replaced by thiazole
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 178